Click here to narrow your options by answering a few questions.

Prostate Cancer
Treatment Guide™

Treatment
Description
Prostate Cancer
Patient Profile
Prostate Cancer
Treatments
Prostate Cancer
Survival Rates
Prostate Cancer
Side Effects
Therapy News View Procedures Share Your Experience

Radiation
Therapy

Prostate Radiation Therapy

EBRT or electron beam radiation therapy aims external radiation at prostate cancer cells. Prostate Radiation
Therapy

EBRT or electron beam radiation therapy aims external radiation at prostate cancer cells.

click to learn more

Learn More

Using Radiation Therapy

IMRT and 3D-CRT are newer versions of EBRT and are non-invasive. Using Radiation Therapy

IMRT and 3D-CRT are newer versions of EBRT and are non-invasive.

click to learn more

Learn More

Radiation Treatment

Radiation therapy generally requires 5 treatments per week over 6-8 weeks. Radiation Treatment

Radiation therapy generally requires 5 treatments per week over 6-8 weeks.

click to learn more

Learn More

External Radiation Outcomes

Multiple long- and short-term studies indicate success rates over 85% especially when used with other therapies. External Radiation
Outcomes

Multiple long- and short-term studies indicate success rates over 85% especially when used with other therapies.

click to learn more

Learn More

Radiation
Side Effects

May include tiredness, diarrhea, skin irritation, upset stomach, frequent or burning urination, and proctitis. Radiation
Side Effects

May include tiredness, diarrhea, skin irritation, upset stomach, frequent or burning urination, and proctitis.

click to learn more

Learn More

Prostate News

Click here for the latest news on Radiation Therapy.Prostate News

Click here for the latest news on Radiation Therapy.

click to learn more

Learn More

Radiation Therapy
Videos

Click here to view Radiation Therapy procedures. Radiation Therapy
Videos

Click here to view Radiation Therapy procedures.

click to learn more

Learn More

Radiation Therapy
Experiences


Click here to share your Radiation Therapy experiences.Radiation Therapy
Experiencse

Click here to share your Radiation Therapy experiences.

click to learn more


Learn More

Brachytherapy

Chemotherapy

Cryotherapy & Cryosurgery

Hormone
Therapy

Prostatectomy

Robotic Prostatectomy

Watchful
Waiting

Complementary
and
Alternative Medicine

High Intensity
Focused
Ultrasound (HIFU)

Emerging Technologies

 

Results of Treating Prostate Cancer with Radiation Therapy and Cryotherapy

“Results of Salvage Cryoablation of the Prostate After Radiation: Identifying Predictors of Treatment Failures and Complications”
Joseph L. Chin,* Stephen E. Pautler, Vladamir Mouraviev,† Naju Touma, Kimberly Moore and Donal B. Downey. The Journal Of Urology® Vol. 165, 1937–1942, June 2001 Copyright © 2001 by American Urological Association, Inc.

Physicians in this study tracked 118 patients with proven local recurrence for 6, 12, and 24 months that had received cryotherapy after full dose radiotherapy. Patients were placed into one of three risk groups based on clinical characteristics. The results revealed that 114 had a PSA less than .5 after 18.6 months. Only 7 patients or 3.1% (23 of 745) showed a biopsy core containing persistent cancer. Approximately 87% remained free of histologic failure. Those with a PSA level greater than 4 exhibited 68% biochemical failure, at 2 it reached 55%, and at .5 it reached 34%. Prior to cryotherapy patient who had a PSA greater than 10, a Gleason score of 8 or greater before radiation, and a stage T3/T4 did not respond as well.


“Results of Salvage Cryoablation of the Prostate After Radiation:: Identifying Predictors of Treatment Failures and Complications”
CHIN, JOSEPH L.; PAUTLER, STEPHEN E.; MOURAVIEV, VLADAMIR; TOUMA, NAJU; MOORE, KIMBERLY; DOWNEY, DONAL B. Journal of Urology. 165(6, Part 1 of 2):1937-1942, June 2001.

In this study 125 cryoablation procedures were performed in 118 patients with proven local recurrence after full dose radiotherapy. At 6, 12, and 24 months doctors tracked patients PSA levels and biopsy results. Based on T stage, Gleason score, prior PSA, and endocrine therapy status patients were placed into different cohorts and analyzed accordingly. Out of 118, 114 patients had a PSA nadir less than 0.5ng/mL. From the biopsy results, 7 patients (3.1%) were found to have contained persistent viable cancer. Eighty seven percent of patients were free of histological failure. There were 68% with a PSA greater than 4 that were free from biochemical failure, 55% with a PSA of 2, and 34% with a PSA of 0.5. Complications consisted of 4 rectourethral fistulas (3.3%) and 6.7% had severe incontinence.

 
 
 
 

 
Prostate Cancer Patient Discussion Group

 

 
 
 

Coping with Prostate Cancer      Are You at Risk for Prostate Cancer?      Prostate Cancer News     Glossary

 Home     Contact Us     Disclaimer    Privacy Policy     Resources     Add URL      Site Map